Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
42.21
+0.76 (1.83%)
At close: May 1, 2026, 4:00 PM EDT
43.30
+1.09 (2.58%)
After-hours: May 1, 2026, 7:47 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3 billion as of May 1, 2026. Its market cap has increased by 182.33% in one year.
Market Cap
3.00B
Enterprise Value
1.56B
1-Year Change
182.33%
Ranking
Category
Stock Price
$42.21
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.00B, an increase of 446.61%. That is a compound annual growth rate of 68.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.00B | -37.61% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 3.26B |
| Arcus Biosciences | 3.23B |
| Alumis | 3.20B |
| Oruka Therapeutics | 3.14B |
| Erasca | 3.12B |
| Beam Therapeutics | 3.08B |
| Tango Therapeutics | 3.03B |
| Arcutis Biotherapeutics | 2.92B |